ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CLLN Carillion Plc

14.20
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Carillion Plc LSE:CLLN London Ordinary Share GB0007365546 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 14.20 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Carillion PLC Oman - letter of award for contract (5437W)

15/11/2017 7:01am

UK Regulatory


Carillion (LSE:CLLN)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Carillion Charts.

TIDMCLLN

RNS Number : 5437W

Carillion PLC

15 November 2017

15 November 2017

Carillion Joint Venture signs letter of award for contract in Oman

Carillion Alawi, a 50:50 Joint Venture with the Zawawi family, has signed a letter of award with the Oman Ministry of Health as the preferred bidder in respect of the design and build of the New Sultan Qaboos Hospital in Salalah. The contract has an estimated value of cGBP240 million to the Joint Venture.

The contract will consist of a two stage design and build process. The initial design and mobilisation phase, which will be directly funded by the customer, will commence immediately. The second phase would commence in 2018 once the design has been completed, the contract executed and funding finalised.

A further letter of award is due to be signed shortly by Carillion Alawi, also with the Oman Ministry of Health, in respect of a hospital in Khasab. The contract is on similar terms to those for the Salalah award and, if it were to go ahead, would have an estimated value of cGBP120m to the Joint Venture.

Both contracts are procured via lower risk procurement routes, for example through seeking support from UK Export Finance to secure project finance for customers. The Group continues to look at ways in which it can de-risk its operations in the Middle East, working with its partners in the region to secure the future of this business.

This and other Carillion news releases can be found at www.carillionplc.com.

For more information

Kellie McAvoy, Head of Investor Relations, or,

John Denning, Director Group Corporate Affairs, Carillion plc +44 (0) 1902 906333

Teneo Blue Rubicon

Charles Armitstead/Haya Herbert-Burns +44 (0) 207 420 3197

This information is provided by RNS

The company news service from the London Stock Exchange

END

CNTGGGMCGUPMUQA

(END) Dow Jones Newswires

November 15, 2017 02:01 ET (07:01 GMT)

1 Year Carillion Chart

1 Year Carillion Chart

1 Month Carillion Chart

1 Month Carillion Chart

Your Recent History

Delayed Upgrade Clock